Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Moisset

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Pharmacology|November 20, 2001
Gene therapy: a strategy for the treatment of inherited muscle diseases?P A Moisset, J P Tremblay
Gene Therapy|February 4, 1999
Expression of human dystrophin following the transplantation of genetically modified mdx myoblastsP A Moisset, Y Gagnon, G Karpati, et al.
Journal of Leukocyte Biology|April 1, 1997
Inflammatory damage following first-generation replication-defective adenovirus controlled by anti-LFA-1B Guérette, P A Moisset, C Huard, et al.
Protein Engineering|October 31, 2000
Functional EGFP-dystrophin fusion proteins for gene therapy vector developmentP Chapdelaine, P A Moisset, P Campeau, et al.
Biochemical and Biophysical Research Communications|June 24, 1998
Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigeneP A Moisset, D Skuk, I Asselin, et al.
Biochemical and Biophysical Research Communications|August 15, 1998
Transplantation of dermal fibroblasts expressing MyoD1 in mouse musclesC Huard, P A Moisset, A Dicaire, et al.
Biochemical and Biophysical Research Communications|June 2, 2000
Transplantation of normal and DMD myoblasts expressing the telomerase gene in SCID miceS Seigneurin-Venin, V Bernard, P A Moisset, et al.
Human Gene Therapy|July 13, 2000
Systemic production of human granulocyte colony-stimulating factor in nonhuman primates by transplantation of genetically modified myoblastsP A Moisset, L Bonham, D Skuk, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Pharmacology|November 20, 2001
Gene therapy: a strategy for the treatment of inherited muscle diseases?P A Moisset, J P Tremblay
Gene Therapy|February 4, 1999
Expression of human dystrophin following the transplantation of genetically modified mdx myoblastsP A Moisset, Y Gagnon, G Karpati, et al.
Journal of Leukocyte Biology|April 1, 1997
Inflammatory damage following first-generation replication-defective adenovirus controlled by anti-LFA-1B Guérette, P A Moisset, C Huard, et al.
Protein Engineering|October 31, 2000
Functional EGFP-dystrophin fusion proteins for gene therapy vector developmentP Chapdelaine, P A Moisset, P Campeau, et al.
Biochemical and Biophysical Research Communications|June 24, 1998
Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigeneP A Moisset, D Skuk, I Asselin, et al.
Biochemical and Biophysical Research Communications|August 15, 1998
Transplantation of dermal fibroblasts expressing MyoD1 in mouse musclesC Huard, P A Moisset, A Dicaire, et al.
Biochemical and Biophysical Research Communications|June 2, 2000
Transplantation of normal and DMD myoblasts expressing the telomerase gene in SCID miceS Seigneurin-Venin, V Bernard, P A Moisset, et al.
Human Gene Therapy|July 13, 2000
Systemic production of human granulocyte colony-stimulating factor in nonhuman primates by transplantation of genetically modified myoblastsP A Moisset, L Bonham, D Skuk, et al.
Pageof 1